UF Diabetes Institute Seminar Series

Monday, November 6, 2017

“Engineering Primary Human T cell with Cas9 Ribonuceloproteins”

12:00 p.m. – 1:00 p.m.
Communicore, C1-11

Kathrin Schumann, Ph.D. 

Diabetes Research Candidate
Postdoctoral Fellow
Diabetes Center
University of California San Francisco

Monday, November 11, 2017

“Identifying Antigen Specific Cells in Type 1 Diabetes and Pathways for T Cell Tolerance”

12:00 p.m. – 1:00 p.m.
Communicore, C1-4

 Brian Fife, Ph.D. 

Diabetes Research Candidate
Associate Professor
Department of Medicine
University of Minnesota

Monday, December 11, 2017

“Thiol-Dependent Signaling & Autoimmune Dysregulation in Type 1 Diabetes”

12:00 p.m. – 1:00 p.m.
Communicore, C1-4

Hubert Tse, Ph.D. 

Diabetes Research Candidate
Associate Professor
Department of Microbiology
Comprehensive Diabetes Center
University of Alabama at Birmingham

Monday, January 22, 2018

“Integration of longitudinal data defines the dynamic nature of the immune response in T1D”

12:00 p.m. – 1:00 p.m.
Communicore, C1-4

Jane Buckner, M.D. 

President
Benaroya Research Institute

 

Monday, January 29, 2018

“Manipulating the DNA Damage Response for the Treatment of Type 1 Diabetes”

12:00 p.m. – 1:00 p.m.
Communicore, C1-4

Jonathan Katz, Ph.D. 

Professor of Pediatrics
Divisions of Immunobiology
Cincinnati Children’s Hospital Medical Center
University of Cincinnati College of Medicine

Monday, February 12, 2018

“Prospects for Primary Prevention of Type 1 Diabetes”

12:00 p.m. – 1:00p.m.
Communicore, C1-4

Richard A. Insel, M.D. 

Scientific Consultant
Janssen Pharmaceuticals
United States

headshot of Richard Insel